MetaCap

Who Owns Enliven Therapeutics Stock?

NASDAQ: ELVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.53+0.12 (+0.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
116.09%
Institutional holders
307
  • Institutions 93.8%
  • Insiders 6.2%
  • Public and other 0.0%

Who owns Enliven Therapeutics stock?

Institutional investors own about 116.1% of Enliven Therapeutics's shares, spread across 307 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.19% of ELVN.

The largest institutional holders are FMR, LLC (14.71%), Orbimed Advisors LLC. (9.21%) and Polar Capital Holdings PLC (8.73%). Together, the top 10 institutions control 61.2% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their ELVN positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ELVN

Enliven Therapeutics top institutional holders
InstitutionShares% HeldChange
FMR, LLC10.83M14.71%+8.0%
Orbimed Advisors LLC.6.78M9.21%0.0%
Polar Capital Holdings PLC6.43M8.73%-0.1%
Blackrock Inc.5.71M7.76%+31.0%
Commodore Capital Lp3.27M4.45%0.0%
Vestal Point Capital, LP3.23M4.38%-19.4%
Vanguard Capital Management LLC2.89M3.93%+12.6%
Price (T.Rowe) Associates Inc2.35M3.19%-19.1%
Fairmount Funds Management LLC1.86M2.52%0.0%
Geode Capital Management, LLC1.71M2.32%+21.4%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ELVN

Enliven Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.88M2.56%
iShares Trust-iShares Russell 2000 ETF1.51M2.05%
Fidelity Select Portfolios-Select Health Care Portfolio1.28M1.74%
Fidelity Securities Fund-Fidelity Small Cap Growth Fund1.25M1.70%
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 1.12M1.53%
T. Rowe Price New Horizons Fund, Inc.807.33K1.10%
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund704.26K0.96%
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund648.11K0.88%
T. Rowe Price Health Sciences Fund, Inc.647.45K0.88%
Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund630.00K0.86%

Frequently asked questions

Who is the largest shareholder of Enliven Therapeutics?

FMR, LLC is the largest institutional shareholder of ELVN, owning 14.71% of shares outstanding (10.83M shares) as of its latest 13F filing.

What percentage of Enliven Therapeutics is owned by institutions?

Institutions own about 116.1% of ELVN shares and 123.8% of the public float.

How much of Enliven Therapeutics do insiders own?

Insiders, such as officers and directors, own about 6.19% of ELVN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related